Quick Answer
iBio, Inc. reported Total Revenue of $400.0 thousand for fiscal year 2025.
iBio, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $400.0K | +77.8% |
| 2024 | $225.0K | — |
| 2023 | $0.00 | -100.0% |
| 2022 | $1.88M | -20.5% |
| 2021 | $2.37M | +44.7% |
| 2020 | $1.64M | -18.8% |
| 2019 | $2.02M | +354.5% |
| 2018 | $444.0K | +12.7% |
| 2017 | $394.0K | -58.4% |
| 2016 | $948.0K | -48.8% |
| 2015 | $1.85M | +802.9% |
| 2014 | $205.0K | -79.6% |
| 2013 | $1.01M | -21.1% |
| 2012 | $1.28M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.00 | -100.0% | -100.0% |
| September 30, 2025 | $100.0K | — | — |
| March 31, 2025 | $0.00 | — | -100.0% |
| December 31, 2024 | $200.0K | — | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $50.0K | — | — |
| March 31, 2023 | $0.00 | -100.0% | — |
| December 31, 2022 | $0.00 | — | — |
- iBio, Inc. showed an increase of +77.8% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2025 period, iBio, Inc.’s total revenue has declined by 68.7% (from $1.28 million to $400.0 thousand).
- The most recent figure is from iBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: